The Johnson & Johnson COVID-19 vaccine “is no longer available in the U.S.,” the U.S. Centers for Disease Control and Prevention (CDC) stated in a recent update.
That’s due to the vaccine expiring on May 7. Health care workers were advised to dispose of any remaining doses in accordance with regulations.
But uptake slowed after U.S. authorities paused recommending the vaccine because of concerns about a reported link to a combination of blood clotting and low platelet levels, a condition called thrombosis with thrombocytopenia syndrome (TTS) that can cause death. About 15 percent of the post-vaccination TTS cases have been fatal.
Regulators limited the availability of the vaccine in 2022 because experts determined it caused TTS.
Since March, recipients have also been warned that they face an increased risk of myocarditis, or heart inflammation, and a related condition called pericarditis. All four COVID-19 vaccines authorized in the United States present an increased risk of myocarditis, primarily for young males.
As of May 11, 19 million Johnson & Johnson shots have been administered, compared to more than 403 million Pfizer shots, more than 252 million Moderna shots, and about 89,000 Novavax shots, according to data reported to the CDC.
It is not mRNA. That is the reason.
Still used a different mechanism to invade cells and reprogram them... was pretty much the same.
Yep. “Viral-vector”.
This is a misconception. Go listen to Dr. Tennpenny. It is exactly the same.
It is mRNA just delivered differently.
The Johnson & Johnson COVID-19 vaccine “is no longer available in the U.S.,” the U.S. Centers for Disease Control and Prevention (CDC) stated in a recent update.
That’s due to the vaccine expiring on May 7. Health care workers were advised to dispose of any remaining doses in accordance with regulations.
But uptake slowed after U.S. authorities paused recommending the vaccine because of concerns about a reported link to a combination of blood clotting and low platelet levels, a condition called thrombosis with thrombocytopenia syndrome (TTS) that can cause death. About 15 percent of the post-vaccination TTS cases have been fatal.
Regulators limited the availability of the vaccine in 2022 because experts determined it caused TTS.
Since March, recipients have also been warned that they face an increased risk of myocarditis, or heart inflammation, and a related condition called pericarditis. All four COVID-19 vaccines authorized in the United States present an increased risk of myocarditis, primarily for young males.
As of May 11, 19 million Johnson & Johnson shots have been administered, compared to more than 403 million Pfizer shots, more than 252 million Moderna shots, and about 89,000 Novavax shots, according to data reported to the CDC.
And just like that the only non-MRNA vaccine vanishes magically.
As I stated above this is a misconception. Go listen to Dr. Tennpenny. It is exactly the same.
It is mRNA just delivered differently.
Baffling...
I'm sorry for your hearing loss fren.😒
Stop the vaccination suddenly no more variants.